Puma Biotechnology, Inc.PBYINASDAQ
Loading
Cash Flow PerformanceStrong
Percentile Rank100
5Y CAGR+120.6%
Studio
Year-over-Year Change

Cash generated from core business operations

5Y CAGR
+120.6%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
52.3x
Strong expansion
Streak
3 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$41.80M+7.4%
2024$38.92M+44.1%
2023$27.01M+270.7%
2022$-15.83M-176.6%
2021$20.65M+2481.3%
2020$800000.00-96.4%
2019$22.38M+192.8%
2018$-24.10M+86.0%
2017$-172.50M-21.7%
2016$-141.70M-